Literature DB >> 18213616

Multiple OPR genes influence personality traits in substance dependent and healthy subjects in two American populations.

Xingguang Luo1, Lingjun Zuo, Henry Kranzler, Huiping Zhang, Shuang Wang, Joel Gelernter.   

Abstract

Personality traits are among the most complex quantitative traits. Certain personality traits are associated with substance dependence (SD); genetic factors may influence both. Associations between opioid receptor (OPR) genes and SD have been reported. This study investigated the relationship between OPR genes and personality traits in a case-control sample. We assessed dimensions of the five-factor model of personality in 556 subjects: 250 with SD [181 European-Americans (EAs) and 69 African-Americans (AAs)] and 306 healthy subjects (266 EAs and 40 AAs). We genotyped 20 OPRM1 markers, 8 OPRD1 markers, and 7 OPRK1 markers, and 38 unlinked ancestry-informative markers in these subjects. The relationships between OPR genes and personality traits were examined using MANCOVA, controlling for gene-gene interaction effects and potential confounders. Associations were decomposed by Roy-Bargmann Stepdown ANCOVA. We found that personality traits were associated as main or interaction effects with the haplotypes, diplotypes, alleles and genotypes at the three OPR genes (0.002 < P < 0.046 from MANCOVA; 0.0004 < P < 0.049 from ANCOVA). Diplotype TTAGGA/TTCAGA at OPRM1 had main effects on Extraversion (P = 0.008), and diplotypes OPRM1(insertion mark)TTCAGA/TTCAGA and OPRD1(insertion mark)CAC/TAC had interaction effects on Openness (P = 0.010) after conservative correction for multiple testing. The present study demonstrates that the genes encoding the mu-, delta-, and kappa-opioid receptors may contribute to variation in personality traits. Further, the three OPR genes have significant interaction effects on personality traits. This work provides additional evidence that personality traits and SD have a partially overlapping genetic basis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18213616      PMCID: PMC3162230          DOI: 10.1002/ajmg.b.30701

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  40 in total

1.  Haploview: analysis and visualization of LD and haplotype maps.

Authors:  J C Barrett; B Fry; J Maller; M J Daly
Journal:  Bioinformatics       Date:  2004-08-05       Impact factor: 6.937

2.  Practical population group assignment with selected informative markers: characteristics and properties of Bayesian clustering via STRUCTURE.

Authors:  Bao-Zhu Yang; Hongyu Zhao; Henry R Kranzler; Joel Gelernter
Journal:  Genet Epidemiol       Date:  2005-05       Impact factor: 2.135

Review 3.  Endogenous opioid systems and alcohol addiction.

Authors:  A Herz
Journal:  Psychopharmacology (Berl)       Date:  1997-01       Impact factor: 4.530

Review 4.  Stability and change in personality assessment: the revised NEO Personality Inventory in the year 2000.

Authors:  P T Costa; R R McCrae
Journal:  J Pers Assess       Date:  1997-02

5.  The effect of repeated administration of morphine, cocaine and ethanol on mu and delta opioid receptor density in the nucleus accumbens and striatum of the rat.

Authors:  J Turchan; B Przewłocka; G Toth; W Lasoń; A Borsodi; R Przewłocki
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

Review 6.  Opioid antagonists for alcohol dependence.

Authors:  M Srisurapanont; N Jarusuraisin
Journal:  Cochrane Database Syst Rev       Date:  2005-01-25

7.  Redefinition of the human kappa opioid receptor gene (OPRK1) structure and association of haplotypes with opiate addiction.

Authors:  Vadim Yuferov; David Fussell; K Steven LaForge; David A Nielsen; Derek Gordon; Ann Ho; Suzanne M Leal; Jurg Ott; Mary Jeanne Kreek
Journal:  Pharmacogenetics       Date:  2004-12

Review 8.  Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, part 1.

Authors:  George A Kenna; John E McGeary; Robert M Swift
Journal:  Am J Health Syst Pharm       Date:  2004-11-01       Impact factor: 2.637

9.  Association between a delta opioid receptor gene polymorphism and heroin dependence in man.

Authors:  P Mayer; H Rochlitz; E Rauch; H Rommelspacher; H E Hasse; S Schmidt; V Höllt
Journal:  Neuroreport       Date:  1997-07-28       Impact factor: 1.837

10.  Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction.

Authors:  C Bond; K S LaForge; M Tian; D Melia; S Zhang; L Borg; J Gong; J Schluger; J A Strong; S M Leal; J A Tischfield; M J Kreek; L Yu
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

View more
  12 in total

1.  A C17T polymorphism in the mu opiate receptor is associated with quantitative measures of drug use in African American women.

Authors:  Howard A Crystal; Sara Hamon; Matthew Randesi; Judith Cook; Kathryn Anastos; Jason Lazar; Chenglong Liu; Leigh Pearce; Elizabeth Golub; Victor Valcour; Kathleen M Weber; Susan Holman; Ann Ho; Mary Jeanne Kreek
Journal:  Addict Biol       Date:  2010-11-11       Impact factor: 4.280

2.  Genetic variation in personality traits explains genetic overlap between borderline personality features and substance use disorders.

Authors:  Lauren R Few; Julia D Grant; Timothy J Trull; Dixie J Statham; Nicholas G Martin; Michael T Lynskey; Arpana Agrawal
Journal:  Addiction       Date:  2014-08-19       Impact factor: 6.526

3.  Pharmacogenomics study in a Taiwan methadone maintenance cohort.

Authors:  Sheng-Chang Wang; Hsiao-Hui Tsou; Ing-Kang Ho; Keh-Ming Lin; Yu-Li Liu
Journal:  J Food Drug Anal       Date:  2013-12       Impact factor: 6.079

4.  Personality Measurement and Assessment in Large Panel Surveys*

Authors:  Brent Roberts; Joshua J Jackson; Angela L Duckworth; Katherine Von Culin
Journal:  Forum Health Econ Policy       Date:  2011-04-18

Review 5.  Strategies for performing genotype-phenotype association studies in nonhuman primates.

Authors:  Christina S Barr
Journal:  Methods       Date:  2009-06-06       Impact factor: 3.608

Review 6.  Candidate genes for cannabis use disorders: findings, challenges and directions.

Authors:  Arpana Agrawal; Michael T Lynskey
Journal:  Addiction       Date:  2009-04       Impact factor: 6.526

7.  Genetic polymorphisms in the opioid receptor delta 1 (OPRD1) gene are associated with methadone dose in methadone maintenance treatment for heroin dependence.

Authors:  Chiu-Ping Fang; Sheng-Chang Wang; Hsiao-Hui Tsou; Ren-Hua Chung; Ya-Ting Hsu; Shu Chih Liu; Hsiang-Wei Kuo; Tung-Hsia Liu; Andrew C H Chen; Yu-Li Liu
Journal:  J Hum Genet       Date:  2020-01-07       Impact factor: 3.172

8.  Case-control association analysis of polymorphisms in the δ-opioid receptor, OPRD1, with cocaine and opioid addicted populations.

Authors:  R C Crist; L M Ambrose-Lanci; M Vaswani; T K Clarke; A Zeng; C Yuan; T N Ferraro; H Hakonarson; K M Kampman; C A Dackis; H M Pettinati; C P O'Brien; D W Oslin; G A Doyle; F W Lohoff; W H Berrettini
Journal:  Drug Alcohol Depend       Date:  2012-07-12       Impact factor: 4.492

9.  ADH1A variation predisposes to personality traits and substance dependence.

Authors:  Lingjun Zuo; Joel Gelernter; Henry R Kranzler; Murray B Stein; Huiping Zhang; Feng Wei; Srijan Sen; James Poling; Xingguang Luo
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-03-05       Impact factor: 3.568

10.  Use of diplotypes - matched haplotype pairs from homologous chromosomes - in gene-disease association studies.

Authors:  Lingjun Zuo; Kesheng Wang; Xingguang Luo
Journal:  Shanghai Arch Psychiatry       Date:  2014-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.